# NPIPB2

## Overview
The NPIPB2 gene encodes the nuclear pore complex interacting protein family member B2, a protein that plays a significant role in the regulation of nucleocytoplasmic transport. This protein is a component of the nuclear pore complex, which is essential for the transport of molecules between the nucleus and the cytoplasm, thereby maintaining cellular homeostasis and regulating gene expression. NPIPB2 is particularly active in the nuclear envelope, where it is involved in critical cellular processes such as cell cycle regulation and signal transduction (Kontopodis2024Uniquome:). The gene's expression is notably altered in certain disease states, including T-cell prolymphocytic leukemia, where it is up-regulated in specific molecular subgroups, indicating its potential role in disease progression (Mikhaylenko2022Computational). Additionally, NPIPB2 is implicated in neurodegenerative diseases due to its involvement in the nuclear pore complex, highlighting its importance in both normal cellular function and disease pathology (Kontopodis2024Uniquome:).

## Function
NPIPB2 is a member of the nuclear pore complex interacting protein family, which plays a crucial role in the regulation of nucleocytoplasmic transport. This protein is involved in the transport of molecules between the nucleus and the cytoplasm, a process essential for maintaining cellular homeostasis and regulating gene expression. NPIPB2 is active in the nuclear envelope, where it contributes to various cellular processes, including cell cycle regulation and signal transduction (Kontopodis2024Uniquome:).

In the context of T-cell prolymphocytic leukemia (T-PLL), NPIPB2 is up-regulated in specific molecular subgroups, suggesting its involvement in the disease's progression. However, the specific function of NPIPB2 in healthy human cells is not detailed in the available studies (Mikhaylenko2022Computational). The protein's role in healthy cells likely involves its participation in the nuclear pore complex, influencing the transport of proteins and RNA, which is critical for normal cellular function and response to signaling pathways. Understanding NPIPB2's function in healthy cells could provide insights into its potential roles in disease states and inform therapeutic strategies.

## Clinical Significance
The NPIPB2 gene, a member of the nuclear pore complex interacting protein family, has been implicated in various diseases due to its altered expression levels. In T-cell prolymphocytic leukemia (T-PLL), NPIPB2 expression is notably up-regulated in the molecular subgroup SG3. This up-regulation is part of a broader pattern of gene expression alterations that may influence the proliferation of T-PLL cells, suggesting that NPIPB2 could be a potential target for drug-based interventions in this leukemia subtype (Mikhaylenko2022Computational).

In contrast, NPIPB2 is among the top downregulated genes in individuals carrying ASXL1 mutations, a type of Clonal Hematopoiesis of Indeterminate Potential (CHIP) mutation. These mutations are associated with significant changes in gene expression, particularly affecting pathways involved in intracellular translation and cardiometabolic traits (Scheidt2023Leukocytes).

The NPIP family, to which NPIPB2 belongs, is also linked to neurodegenerative diseases such as Alzheimer's and Huntington's due to its role in nuclear pore complex function. Abnormalities in this complex can lead to disruptions in nucleocytoplasmic transport, which are critical in the pathogenesis of these conditions (Kontopodis2024Uniquome:).


## References


1. (Kontopodis2024Uniquome:) Uniquome: Construction and Decoding of a Novel Proteomic Atlas that Contains New Peptide Entities. This article has 0 citations.

2. (Scheidt2023Leukocytes) Leukocytes carryingClonal Hematopoiesis of Indeterminate Potential(CHIP) Mutations invade Human Atherosclerotic Plaques. This article has 2 citations.

[3. (Mikhaylenko2022Computational) Nathan Mikhaylenko, Linus Wahnschaffe, Marco Herling, Ingo Roeder, and Michael Seifert. Computational gene expression analysis reveals distinct molecular subgroups of t-cell prolymphocytic leukemia. PLOS ONE, 17(9):e0274463, September 2022. URL: http://dx.doi.org/10.1371/journal.pone.0274463, doi:10.1371/journal.pone.0274463. This article has 2 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0274463)